Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Summary

Massive blood loss occurs in metastatic spinal tumor resection and may cause severe complications. The objective of this study is to investigate whether the use of tranexamic acid will reduce perioperative and postoperative bleeding when compared to those without use of tranexamic acid.

Eligibility

Inclusion Criteria:

* Diagnosed as metastatic carcinoma of the thoracolumbar spine
* solitary neoplasm involve only one segment of spine
* patients underwent separation surgery

Exclusion Criteria:

* coagulation function was abnormal preoperatively
* patients are allergic to tranexamic acid
* neoplasm involve more than one segment of spine
* patients with rich blood supply who need embolization

Conditions3

Interventions2

Related trials

• Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial — RenJi Hospital
• Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia — University of Manitoba
• Perioperative Treatment With Tranexamic Acid in Melanoma — University of Aarhus
• Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) — Ottawa Hospital Research Institute
• Tranexamic Acid During Colonic Endoscopic Resection Procedures — Assaf-Harofeh Medical Center
• The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients — Stanford University
• A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients — M.D. Anderson Cancer Center
• Role of TXA in Patients Undergoing Breast Free Flap Reconstruction — University of Virginia

Browse More Trials